122 related articles for article (PubMed ID: 38677733)
1. Riluzole Reverses a Number of Undesirable Effects of Dexamethasone in Glioblastoma Cells.
Keul J; Sperling S; Rohde V; Mielke D; Ninkovic M
Anticancer Res; 2024 May; 44(5):1829-1835. PubMed ID: 38677733
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.
Shannon S; Vaca C; Jia D; Entersz I; Schaer A; Carcione J; Weaver M; Avidar Y; Pettit R; Nair M; Khan A; Foty RA
PLoS One; 2015; 10(8):e0135951. PubMed ID: 26284619
[TBL] [Abstract][Full Text] [Related]
3. Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
Yamada T; Tsuji S; Nakamura S; Egashira Y; Shimazawa M; Nakayama N; Yano H; Iwama T; Hara H
J Neurosurg; 2020 Mar; 134(3):701-710. PubMed ID: 32168477
[TBL] [Abstract][Full Text] [Related]
4. Advantages and drawbacks of dexamethasone in glioblastoma multiforme.
Afshari AR; Sanati M; Aminyavari S; Shakeri F; Bibak B; Keshavarzi Z; Soukhtanloo M; Jalili-Nik M; Sadeghi MM; Mollazadeh H; Johnston TP; Sahebkar A
Crit Rev Oncol Hematol; 2022 Apr; 172():103625. PubMed ID: 35158070
[TBL] [Abstract][Full Text] [Related]
5. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
6. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone.
Kaup B; Schindler I; Knüpfer H; Schlenzka A; Preiss R; Knüpfer MM
J Neurooncol; 2001 Jan; 51(2):105-10. PubMed ID: 11386406
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone Suppresses IL-33-exacerbated Malignant Phenotype of U87MG Glioblastoma Cells
Ai J; Weng Y; Jiang L; Liu C; Liu H; Chen H
Anticancer Agents Med Chem; 2024; 24(5):389-397. PubMed ID: 38192141
[TBL] [Abstract][Full Text] [Related]
9. Combined Applications of Repurposed Drugs and Their Detrimental Effects on Glioblastoma Cells.
Sachkova A; Sperling S; Mielke D; Schatlo B; Rohde V; Ninkovic M
Anticancer Res; 2019 Jan; 39(1):207-214. PubMed ID: 30591460
[TBL] [Abstract][Full Text] [Related]
10. Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
Koch MS; Zdioruk M; Nowicki MO; Griffith AM; Aguilar E; Aguilar LK; Guzik BW; Barone F; Tak PP; Tabatabai G; Lederer JA; Chiocca EA; Lawler S
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017150
[TBL] [Abstract][Full Text] [Related]
11. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
[TBL] [Abstract][Full Text] [Related]
13. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
Miekus K; Kijowski J; Sekuła M; Majka M
Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay.
Meleis AM; Mahtabfar A; Danish S; Foty RA
PLoS One; 2017; 12(10):e0186483. PubMed ID: 29040322
[TBL] [Abstract][Full Text] [Related]
15. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS
Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.
Nair M; Romero J; Mahtabfar A; Meleis AM; Foty RA; Corbett SA
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443896
[TBL] [Abstract][Full Text] [Related]
17. Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity.
Doan P; Nguyen P; Murugesan A; Candeias NR; Yli-Harja O; Kandhavelu M
Cells; 2021 Aug; 10(8):. PubMed ID: 34440745
[TBL] [Abstract][Full Text] [Related]
18. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.
Lindemann C; Marschall V; Weigert A; Klingebiel T; Fulda S
Neoplasia; 2015 Jun; 17(6):481-9. PubMed ID: 26152356
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
20. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
